Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers

European Journal of Cancer Prevention

Volumn 15, Issue 6, 2006, Pages 474-479

  Ackermann, Sven ^a   Lux, Michael Patrick ^a   Fasching, Peter Andreas ^a   Strissl, Pamela ^a   Renner, Stefan Peter ^a   Poehls, Uwe ^a   Bender, Hans Georg ^b   Beckmann, Matthias Wilhelm ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Genetic testing; Prophylactic hysterectomy; Prophylactic mastectomy; Prophylactic salpingo oophorectomy; Prophylactic surgery

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC SCREENING; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; MASTECTOMY; OUTCOME ASSESSMENT; OVARIECTOMY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SAMPLE SIZE;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENITAL NEOPLASMS, FEMALE; HUMANS; HYSTERECTOMY; MASTECTOMY; MEDICAL HISTORY TAKING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 33751061912     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000220628.62610.ea     Document Type: Article

References (26)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130.
2. Beckmann MW, Lux MP (2004). Hereditäres mammakarzinom. Onkologe 10:20-28.
3. Berends MJ, Wu Y, Sijmons RH, van der Sluis T, Ek WB, Ligtenberg MJ, et al. (2003). Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 21:4364-4370.
4. Boyd J (2003). Specific keynote: hereditary ovarian cancer: what we know. Gynecol Oncol 88:S8-S10.
5. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S (2004). Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 96:122-133.
6. Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM (2003). Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 178:77-81.
7. Easton DF (2002). Familial risks of breast cancer. Breast Cancer Res 4:179-181.
8. Easton DF, Ford D, Bishop DT (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271.
9. Eisinger F, Julian-Reynier C, Sobol H, Stoppa-Lyonnet D, Lasset C, Nogues C (2000). Acceptability of prophylactic mastectomy in cancer-prone women. JAMA 283:202-203.
10. Eisinger F, Stoppa-Lyonnet D, Lasset C, Vennin P, Chabal F, Nogues C, et al. (2001). Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys. Fam Cancer 1:157-162.
11. Geller G, Bernhardt BA, Doksum T, Helzlsouer KJ, Wilcox P, Holtzman NA (1998). Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? J Clin Oncol 16:2868-2876.
12. Horn LC, Raptis G, Fischer U (2002). Familial cancer history in patients with carcinoma of the cervix uteri. Eur J Obstet Gynecol Reprod Biol 101:54-57.
13. Kerlikowske K, Brown JS, Grady DG (1992). Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol 80:700-707.
14. King MC, Marks JH, Mandell JB (2003). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646.
15. Lavie O, Hornreich G, Ben Arie A, Rennert G, Cohen Y, Keidar R, et al. (2004). BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol 92:521-524.
16. Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, et al. (1998). What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 16:1650-1654.
17. Liden A, Berglund G, Hansson MG, Rosenquist R, Sjoden PO, Nordin K (2003). Genetic counselling for cancer and risk perception. Acta Oncol 42:726-734.
18. Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN (2000). What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 18:2484-2492.
19. Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M, Kirk J, et al. (2000). Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18:2250-2257.
20. Metcalfe KA, Semple JL, Narod SA (2005). Time to reconsider subcutaneous mastectomy for breast-cancer prevention? Lancet Oncol 6:431-434.
21. Ponder BA (2001). Cancer genetics. Nature 411:336-341.
22. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van't V, Garber JE, et al. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055-1062.
23. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, et al. (1999). Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91:1475-1479.
24. Rosen EM, Fan S, Pestell RG, Goldberg ID (2003). BRCA1 gene in breast cancer. J Cell Physiol 196:19-41.
25. Schmutzler R, Schlegelberger B, Meindl A, Gerber WD, Kiechle M (2003). Counselling, genetic testing and prevention in women with hereditary breast-and ovarian cancer. Interdisciplinary recommendations of the consortium 'Hereditary Breast- and Ovarian Cancer' of the German Cancer AiD. Zentralbl Gynakol 125:494-506.
26. Stefanek M, Hartmann L, Nelson W (2001). Risk-reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst 93:1297-1306.